Why Some Transferred Fat Survives and Some Does Not: The Biology Behind BBL 'Take'

Patients researching a Brazilian Butt Lift quickly run into a number that sounds alarming: surgeons commonly quote fat retention rates of roughly 60 to 80 percent, meaning 20 to 40 percent of the transferred volume is expected to resorb within the first three to six months. This is often framed as bad luck or poor technique. In reality, it is a predictable consequence of how transplanted tissue survives without a blood supply, and understanding the mechanism explains almost every rule patients are given after surgery.

Grafted fat starts out with no blood supply at all. When fat is harvested by liposuction, the adipocytes, the fat cells themselves, are severed from the capillaries that fed them. Once injected into the buttock, each parcel of fat must survive an ischemic window, a period with no direct circulation, until the body builds new vessels into it. Survival during that window happens through three overlapping phases described in graft science: plasmatic imbibition, where cells passively absorb nutrients from surrounding tissue fluid for the first day or two; inosculation, where existing capillaries in the recipient tissue connect to vessel remnants inside the graft, typically around day two to four; and revascularization, where entirely new capillaries grow into the graft over the following weeks.

The practical implication is geometric. Oxygen and nutrients can only diffuse a short distance into tissue, on the order of 1 to 2 millimeters. Fat cells sitting within that distance of well-perfused recipient tissue tend to survive. Cells at the center of a large, pooled bolus of fat are too far from any blood supply, and they die. This is why experienced surgeons inject fat in thin, threadlike passes distributed across many tunnels rather than depositing large pockets. The goal is to maximize the surface area of contact between graft and living tissue. It is also why the same total volume injected two different ways can produce very different retention.

The recipient site has a capacity limit. The buttock's subcutaneous layer can only accept so much fat before interstitial pressure rises. Overfilling compresses the very capillaries the graft depends on, which paradoxically lowers survival. This is one reason very large single-session augmentations often show more resorption, and why some surgeons stage extremely large volume goals across two procedures rather than forcing everything in at once. More injected is not automatically more retained.

Handling of the fat before injection matters, within limits. Fat is fragile. High suction pressures during harvest, aggressive centrifugation, prolonged exposure to air, and small-diameter injection cannulas can all rupture adipocytes. Ruptured cells release free oil, which does not survive and can contribute to oil cysts or inflammation. Modern protocols favor lower-pressure harvest, gentle washing or decanting to remove blood and tumescent fluid, and minimizing the time between harvest and reinjection. Comparative studies of processing methods, washing versus centrifugation versus filtration, show differences that are real but modest. Technique at the injection stage, meaning distribution and depth, generally influences outcomes more than the choice of processing system.

Depth of injection is now a safety and survival issue at once. Current safety guidance directs fat placement into the subcutaneous plane only, above the gluteal muscle fascia, because intramuscular injection carries the risk of fat entering large gluteal veins and causing fatal pulmonary fat embolism. From a pure graft-take standpoint, muscle is well vascularized, which is why older intramuscular techniques were used. But subcutaneous placement, done in fine distributed passes, achieves reliable retention without the embolism risk, and it has become the accepted standard.

Aftercare rules map directly onto the biology. Instructions to avoid sitting directly on the buttocks for roughly two weeks exist because sustained pressure compresses the fragile new capillary connections forming during inosculation. Nicotine in any form, cigarettes, vapes, or patches, causes vasoconstriction and impairs the revascularization phase, which is why surgeons insist on cessation before and after surgery. Significant weight loss in the first months deprives all fat cells, including grafted ones, of stored energy at exactly the moment they are most vulnerable. Stable weight and adequate protein intake support graft survival for the same reason they support wound healing.

What the final result actually represents. The fat that survives the first three months has established a permanent blood supply and behaves like native tissue. It will gain and lose volume with future weight changes, because surviving adipocytes remain metabolically active. The volume seen immediately after surgery is inflated by swelling and by cells that will not make it, which is why surgeons often overfill modestly in anticipation of resorption, and why the honest assessment point for results is around month three to six, not week one.

The takeaway for anyone comparing consultations: ask surgeons how they distribute fat, what plane they inject into, and what retention they typically observe at six months. A candid answer acknowledging 20 to 40 percent resorption reflects an understanding of the biology. A promise that every milliliter will survive does not.

Related reading: How Much Transferred Fat Actually Survives a BBL, and Why.